Deeper Photoacoustic Imaging for Clinical Translation

Photoacoustic imaging opens a new path to assess medical conditions where in vivo measurements are critical. Our aim is to study light delivery systems, the interaction of light with human placental tissue, and improve the depth resolution of photoacoustic imaging. Successful detection of placental hypoxia will allow us to noninvasively monitor the effect of placental ischemia during human pregnancy. The goal of this project is to develop methods to use photoacoustic imaging to monitor placental oxygenation in a clinical setting.

References

Vincely, V.D., and Bayer, C.L., “Improved estimation of hemoglobin oxygen saturation derived from spectral photoacoustic images within NIR-II,” Gordon 2022 Research Conference: In Vivo Ultrasound Imaging, (14-19 August 2022) [POSTER];

Vincely, V.D., Katakam, S., Kays, J., Dennis., Allison, Bayer, C.L., “Deeper photoacoustic imaging in tissue using an NIR-II contrast agent,” Optica Biophotonics Congress 2022, (27 April 2022);

Huda, K, Swan, KF, Gambala, CT, Bayer CL,. Towards Transabdominal Functional Photoacoustic Imaging of the Placenta: Improvement in Imaging Depth Through Optimization of Light Delivery. Ann Biomed Eng 49, 1861–1873 (2021).

[DOI]

Huda, K., Bayer, CL, “Monte Carlo simulation for improving spectral photoacoustic imaging-based oxygen saturation estimation of human placental tissue,” Proc. SPIE 11240, Photons Plus Ultrasound: Imaging and Sensing 2020, 112400D (17 February 2020);

[DOI]

Huda, K, Kolkin, AD, Bayer, CL, “Improving Spectral Photoacoustic Imaging-Based Oxygen Saturation Estimates of Ex Vivo Human Placenta Through Simulation”, BMES 2019 Annual Meeting, October 19, 2019, Philadelphia, PA.

[DOI]